These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 20056593

  • 1. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.
    Atary JZ, Borleffs CJ, Liem SS, Bax JJ, van der Hoeven BL, Bootsma M, van der Wall EE, van Erven L, Schalij MJ.
    Europace; 2010 Mar; 12(3):378-84. PubMed ID: 20056593
    [Abstract] [Full Text] [Related]

  • 2. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [Abstract] [Full Text] [Related]

  • 3. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
    Belhassen B, Ohayon-Tsioni T, Glick A, Viskin S.
    Isr Med Assoc J; 2009 Sep; 11(9):520-4, 526, 528. PubMed ID: 19960844
    [Abstract] [Full Text] [Related]

  • 4. Defibrillator implantation early after myocardial infarction.
    Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, Kornacewicz-Jach Z, Sredniawa B, Lupkovics G, Hofgärtner F, Lubinski A, Rosenqvist M, Habets A, Wegscheider K, Senges J, IRIS Investigators.
    N Engl J Med; 2009 Oct 08; 361(15):1427-36. PubMed ID: 19812399
    [Abstract] [Full Text] [Related]

  • 5. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.
    Z Kardiol; 2000 Oct 08; 89 Suppl 3():194-205. PubMed ID: 10810803
    [Abstract] [Full Text] [Related]

  • 6. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ.
    Circ Cardiovasc Imaging; 2009 May 08; 2(3):183-90. PubMed ID: 19808591
    [Abstract] [Full Text] [Related]

  • 7. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
    de Jong JS, Marsman RF, Henriques JP, Koch KT, de Winter RJ, Tanck MW, Wilde AA, Dekker LR.
    Am Heart J; 2009 Sep 08; 158(3):467-72. PubMed ID: 19699872
    [Abstract] [Full Text] [Related]

  • 8. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
    Piccini JP, Al-Khatib SM, Myers ER, Anstrom KJ, Buxton AE, Peterson ED, Sanders GD.
    J Cardiovasc Electrophysiol; 2010 Jul 08; 21(7):791-8. PubMed ID: 20132397
    [Abstract] [Full Text] [Related]

  • 9. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
    Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I, Multicenter Automatic Defibrillator Implantation Trial-II Investigators.
    Am J Cardiol; 2010 Mar 01; 105(5):581-6. PubMed ID: 20185000
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
    Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ, DINAMIT Investigators.
    N Engl J Med; 2004 Dec 09; 351(24):2481-8. PubMed ID: 15590950
    [Abstract] [Full Text] [Related]

  • 11. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.
    Circulation; 2008 Apr 15; 117(15):1918-26. PubMed ID: 18391108
    [Abstract] [Full Text] [Related]

  • 12. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?
    Siu CW, Pong V, Ho HH, Liu S, Lau CP, Li SW, Tse HF.
    J Cardiovasc Electrophysiol; 2010 Mar 15; 21(3):231-5. PubMed ID: 19804551
    [Abstract] [Full Text] [Related]

  • 13. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2007 Feb 15; 18(2):181-4. PubMed ID: 17338766
    [Abstract] [Full Text] [Related]

  • 14. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials.
    Yap YG, Duong T, Bland M, Malik M, Torp-Pedersen C, Køber L, Connolly SJ, Marchant B, Camm J.
    Eur Heart J; 2005 Jul 15; 26(14):1385-93. PubMed ID: 15914501
    [Abstract] [Full Text] [Related]

  • 15. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
    Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, Tsurumi Y, Koyanagi R, Kasanuki H, Heart Institute of Japan Acute Myocardial Infarction-II (HIJAMI-II) Investigators.
    Heart; 2009 Mar 15; 95(3):216-20. PubMed ID: 18728065
    [Abstract] [Full Text] [Related]

  • 16. Primary prevention of defibrillator implantation after myocardial infarction: clinical practice and compliance to guidelines.
    Sjöblom J, Ljung L, Frick M, Rosenqvist M, Frykman V.
    Europace; 2012 Apr 15; 14(4):490-5. PubMed ID: 22117032
    [Abstract] [Full Text] [Related]

  • 17. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ, MADIT-II Research Group.
    J Cardiovasc Electrophysiol; 2007 Aug 15; 18(8):833-8. PubMed ID: 17537209
    [Abstract] [Full Text] [Related]

  • 18. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
    Yu H, Oswald H, Gardiwal A, Lissel C, Klein G.
    Am J Cardiol; 2007 Aug 15; 100(4):635-9. PubMed ID: 17697820
    [Abstract] [Full Text] [Related]

  • 19. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML, MADIT-II Investigators.
    J Am Coll Cardiol; 2008 Jan 22; 51(3):288-96. PubMed ID: 18206738
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM, Zhang S, Chen KP, Hua W, Wang FZ, Chen X.
    Chin Med J (Engl); 2009 Apr 05; 122(7):802-6. PubMed ID: 19493393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.